KEAP1 and gastric cancer: WA exhibits potent antitumor activity by inducing both apoptosis and ferroptosis through mechanisms involving oxidative stress and mitochondrial dysfunction, with involvement of the Keap1/Nrf2/HO-1 signaling axis, highlighting its potential as a therapeutic candidate for GC therapy [48].